tiprankstipranks
Aquestive Therapeutics (AQST)
NASDAQ:AQST
US Market

Aquestive Therapeutics (AQST) Cash flow

Compare
2,132 Followers

Aquestive Therapeutics Cash Flow

AQST's free cash flow for Q4 2024 was $-6.50M. For the 2024 fiscal year, AQST's free cash flow was decreased by $-28.54M and operating cash flow was $-6.49M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -35.76M$ -6.38M$ -9.79M$ -32.98M$ -45.46M
Investing Cash Flow
$ -159.00K$ -995.00K$ -2.52M$ -913.00K$ -517.00K
Financing Cash Flow
$ 83.59M$ 3.97M$ 11.56M$ 30.11M$ 28.46M
End Cash Position
$ 71.55M$ 23.87M$ 27.27M$ 28.02M$ 31.81M
Free Cash Flow
$ -35.92M$ -7.38M$ -12.31M$ -33.89M$ -45.98M
Currency in USD

Aquestive Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis